SkyAI Posts $109.5M H1 Loss as Solana Holdings Tumble; Pivots to AI Finance Platform
SKYA sits 27% above its 52-week low of $0.91.
Summary
SkyAI reported a $109.5M net loss for H1 2026 as its Solana treasury lost nearly half its value. The company is pivoting to an AI finance platform while defending against takeovers with a new poison pill.
Key Events · Earnings and Guidance · SKYA
-
Massive Loss on Digital Assets
H1 2026 net loss of $109.5M includes $84.3M unrealized and $14.7M realized losses on Solana holdings. The digital commodity portfolio fell from $250.1M to $144.3M.
-
Strategic Pivot to AI Finance
Company announced a shift to building an agentic finance platform for emerging markets, with a new Hong Kong headquarters. Legacy medical device operations are now discontinued.
-
Poison Pill Adopted
Board adopted a limited-duration stockholder rights plan on May 13, 2026, triggered if any person acquires 15% or more of the company without board approval. This follows the July 17 rejection of an unsolicited takeover bid.
-
Share Buybacks Continue
Repurchased 1,213,669 shares for $2.0M during H1 2026 under the $100M buyback program. $98M remains authorized.
Analysis · SKYA · Crypto Assets
SkyAI's pivot from medical devices to a crypto treasury strategy has backfired dramatically. The company reported a $109.5 million net loss for the first half of 2026, driven by $99 million in combined realized and unrealized losses on its Solana holdings as the token's price plunged. The digital commodity portfolio, once valued at $250 million, has shrunk to $144 million. Against this backdrop, management is attempting another transformation — this time into an AI-powered finance platform targeting emerging markets. The company has established a Hong Kong base and adopted a poison pill, likely in response to the recently rejected unsolicited takeover bid. With only $12 million in cash and a $100 million buyback program largely unused, the runway depends on Solana's recovery or further asset sales at depressed prices.
At the time of this filing, SKYA was trading at $1.16 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $49.1M. The 52-week trading range was $0.91 to $18.23. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.